Guardant Health Launches Patrick Dempsey Campaign for CRC Screening
PALO ALTO, Calif., July 28, 2026 Guardant Health, Inc. has launched a new colorectal cancer (CRC) awareness campaign featuring...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PALO ALTO, Calif., July 28, 2026 Guardant Health, Inc. has launched a new colorectal cancer (CRC) awareness campaign featuring...
PASADENA, Texas, July 15, 2026 Kaneka Nutrients has announced the third phase of its independent Ubiquinol authenticity testing program,...
PONTE VEDRA, Fla., July 15, 2026 Orasis Pharmaceuticals has reached an important international regulatory milestone with the submission of...
NEW YORK, June 30, 2026 Renalytix PLC has announced the publication of groundbreaking two-year real-world evidence (RWE) demonstrating that...
JERSEY CITY, N.J., June 22, 2026 Organon has completed a global licensing agreement with Sebela Pharmaceuticals for MIUDELLA®, a...
SAN DIEGO & MELBOURNE, Australia, June 24, 2026 LENZ Therapeutics has significantly expanded the international commercialization strategy for its...
SAN DIEGO, June 7, 2026 LENZ Therapeutics announced that Everest Medicines has acquired the rights to develop, manufacture, and...
MUMBAI, India, June 2, 2026 Alkem Laboratories has announced the launch of India’s first semaglutide single-shot pre-filled syringes, marking...
GLASGOW, Scotland, June 4, 2026 Otsuka Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Development & Commercialization, Inc. have announced positive...
San Diego, California, USA, April 7, 2026 Broad U.S. Availability Expands Patient Access In a major advancement for rare...
